| Dr Jonathan Benjamin Halevy, MD | |
|
35 Medical Center Pkwy # 101, Augusta, ME 04330-8160 | |
| (207) 430-4321 | |
| Not Available |
| Full Name | Dr Jonathan Benjamin Halevy |
|---|---|
| Gender | Male |
| Speciality | Cardiovascular Disease (cardiology) |
| Experience | 12 Years |
| Location | 35 Medical Center Pkwy # 101, Augusta, Maine |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1649546268 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RC0001X | Internal Medicine - Clinical Cardiac Electrophysiology | MD24513 (Maine) | Secondary |
| 207RC0000X | Internal Medicine - Cardiovascular Disease | MD24513 (Maine) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Maine General Medical Center | Augusta, ME | Hospital |
| Central Maine Medical Center | Lewiston, ME | Hospital |
| Franklin Memorial Hospital | Farmington, ME | Hospital |
| Maine Medical Center | Portland, ME | Hospital |
| Redington Fairview General Hospital | Skowhegan, ME | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Mainegeneral Medical Center | 1254245715 | 487 |
| Central Maine Medical Center | 2567379563 | 347 |
| Mainehealth | 7517860588 | 2067 |
| Redington-fairview General Hospital | 9133018740 | 36 |
| Maine Medical Partners | 9335043967 | 789 |
News Archive
Vitamin D supplements are not an effective treatment for easing painful symptoms of Irritable Bowel Syndrome (IBS), a new study from the University of Sheffield reveals.
The International Society for Stem Cell Research (ISSCR) announced today that it has launched "A Closer Look at Stem Cell Treatments" (www.closerlookatstemcells.org), a Web site to arm patients, their families and doctors with information they need to make decisions about stem cell treatments.
Around 15% of ovarian cancer cases are linked to genetic mutations such as BRCA1, BRCA2 and Lynch Syndrome, which increase an individual's likelihood of developing ovarian and other cancers. This equates to over 1,000 women a year in the UK whose lives could potentially be saved.
The Center for Infection and Immunity at Columbia University's Mailman School today announced that the U.S. Food and Drug Administration has issued an Emergency Use Authorization for the CII-ArboViroPlex rRT-PCR Test, the first multiplex assay that simultaneously tests for the presence of Zika virus, all serotypes of dengue virus, chikungunya virus, and West Nile virus, as well as a host gene that ensures the accuracy of results.
Medtronic, Inc. (NYSE:MDT) today announced financial results for its first quarter of fiscal year 2010, which ended July 31, 2009.
› Verified 1 days ago
| Entity Name | Mainegeneral Medical Center |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1669423380 PECOS PAC ID: 1254245715 Enrollment ID: O20031118000718 |
News Archive
Vitamin D supplements are not an effective treatment for easing painful symptoms of Irritable Bowel Syndrome (IBS), a new study from the University of Sheffield reveals.
The International Society for Stem Cell Research (ISSCR) announced today that it has launched "A Closer Look at Stem Cell Treatments" (www.closerlookatstemcells.org), a Web site to arm patients, their families and doctors with information they need to make decisions about stem cell treatments.
Around 15% of ovarian cancer cases are linked to genetic mutations such as BRCA1, BRCA2 and Lynch Syndrome, which increase an individual's likelihood of developing ovarian and other cancers. This equates to over 1,000 women a year in the UK whose lives could potentially be saved.
The Center for Infection and Immunity at Columbia University's Mailman School today announced that the U.S. Food and Drug Administration has issued an Emergency Use Authorization for the CII-ArboViroPlex rRT-PCR Test, the first multiplex assay that simultaneously tests for the presence of Zika virus, all serotypes of dengue virus, chikungunya virus, and West Nile virus, as well as a host gene that ensures the accuracy of results.
Medtronic, Inc. (NYSE:MDT) today announced financial results for its first quarter of fiscal year 2010, which ended July 31, 2009.
› Verified 1 days ago
| Entity Name | Redington-fairview General Hospital |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1174549133 PECOS PAC ID: 9133018740 Enrollment ID: O20040312000119 |
News Archive
Vitamin D supplements are not an effective treatment for easing painful symptoms of Irritable Bowel Syndrome (IBS), a new study from the University of Sheffield reveals.
The International Society for Stem Cell Research (ISSCR) announced today that it has launched "A Closer Look at Stem Cell Treatments" (www.closerlookatstemcells.org), a Web site to arm patients, their families and doctors with information they need to make decisions about stem cell treatments.
Around 15% of ovarian cancer cases are linked to genetic mutations such as BRCA1, BRCA2 and Lynch Syndrome, which increase an individual's likelihood of developing ovarian and other cancers. This equates to over 1,000 women a year in the UK whose lives could potentially be saved.
The Center for Infection and Immunity at Columbia University's Mailman School today announced that the U.S. Food and Drug Administration has issued an Emergency Use Authorization for the CII-ArboViroPlex rRT-PCR Test, the first multiplex assay that simultaneously tests for the presence of Zika virus, all serotypes of dengue virus, chikungunya virus, and West Nile virus, as well as a host gene that ensures the accuracy of results.
Medtronic, Inc. (NYSE:MDT) today announced financial results for its first quarter of fiscal year 2010, which ended July 31, 2009.
› Verified 1 days ago
| Entity Name | Central Maine Medical Center |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1689653487 PECOS PAC ID: 2567379563 Enrollment ID: O20040324000441 |
News Archive
Vitamin D supplements are not an effective treatment for easing painful symptoms of Irritable Bowel Syndrome (IBS), a new study from the University of Sheffield reveals.
The International Society for Stem Cell Research (ISSCR) announced today that it has launched "A Closer Look at Stem Cell Treatments" (www.closerlookatstemcells.org), a Web site to arm patients, their families and doctors with information they need to make decisions about stem cell treatments.
Around 15% of ovarian cancer cases are linked to genetic mutations such as BRCA1, BRCA2 and Lynch Syndrome, which increase an individual's likelihood of developing ovarian and other cancers. This equates to over 1,000 women a year in the UK whose lives could potentially be saved.
The Center for Infection and Immunity at Columbia University's Mailman School today announced that the U.S. Food and Drug Administration has issued an Emergency Use Authorization for the CII-ArboViroPlex rRT-PCR Test, the first multiplex assay that simultaneously tests for the presence of Zika virus, all serotypes of dengue virus, chikungunya virus, and West Nile virus, as well as a host gene that ensures the accuracy of results.
Medtronic, Inc. (NYSE:MDT) today announced financial results for its first quarter of fiscal year 2010, which ended July 31, 2009.
› Verified 1 days ago
| Entity Name | Maine Medical Partners |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1104921535 PECOS PAC ID: 9335043967 Enrollment ID: O20040331000274 |
News Archive
Vitamin D supplements are not an effective treatment for easing painful symptoms of Irritable Bowel Syndrome (IBS), a new study from the University of Sheffield reveals.
The International Society for Stem Cell Research (ISSCR) announced today that it has launched "A Closer Look at Stem Cell Treatments" (www.closerlookatstemcells.org), a Web site to arm patients, their families and doctors with information they need to make decisions about stem cell treatments.
Around 15% of ovarian cancer cases are linked to genetic mutations such as BRCA1, BRCA2 and Lynch Syndrome, which increase an individual's likelihood of developing ovarian and other cancers. This equates to over 1,000 women a year in the UK whose lives could potentially be saved.
The Center for Infection and Immunity at Columbia University's Mailman School today announced that the U.S. Food and Drug Administration has issued an Emergency Use Authorization for the CII-ArboViroPlex rRT-PCR Test, the first multiplex assay that simultaneously tests for the presence of Zika virus, all serotypes of dengue virus, chikungunya virus, and West Nile virus, as well as a host gene that ensures the accuracy of results.
Medtronic, Inc. (NYSE:MDT) today announced financial results for its first quarter of fiscal year 2010, which ended July 31, 2009.
› Verified 1 days ago
| Entity Name | Mainehealth |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1790265502 PECOS PAC ID: 7517860588 Enrollment ID: O20040701000166 |
News Archive
Vitamin D supplements are not an effective treatment for easing painful symptoms of Irritable Bowel Syndrome (IBS), a new study from the University of Sheffield reveals.
The International Society for Stem Cell Research (ISSCR) announced today that it has launched "A Closer Look at Stem Cell Treatments" (www.closerlookatstemcells.org), a Web site to arm patients, their families and doctors with information they need to make decisions about stem cell treatments.
Around 15% of ovarian cancer cases are linked to genetic mutations such as BRCA1, BRCA2 and Lynch Syndrome, which increase an individual's likelihood of developing ovarian and other cancers. This equates to over 1,000 women a year in the UK whose lives could potentially be saved.
The Center for Infection and Immunity at Columbia University's Mailman School today announced that the U.S. Food and Drug Administration has issued an Emergency Use Authorization for the CII-ArboViroPlex rRT-PCR Test, the first multiplex assay that simultaneously tests for the presence of Zika virus, all serotypes of dengue virus, chikungunya virus, and West Nile virus, as well as a host gene that ensures the accuracy of results.
Medtronic, Inc. (NYSE:MDT) today announced financial results for its first quarter of fiscal year 2010, which ended July 31, 2009.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Jonathan Benjamin Halevy, MD 35 Medical Center Pkwy # 101, Augusta, ME 04330-8160 Ph: (207) 430-4321 | Dr Jonathan Benjamin Halevy, MD 35 Medical Center Pkwy # 101, Augusta, ME 04330-8160 Ph: (207) 430-4321 |
News Archive
Vitamin D supplements are not an effective treatment for easing painful symptoms of Irritable Bowel Syndrome (IBS), a new study from the University of Sheffield reveals.
The International Society for Stem Cell Research (ISSCR) announced today that it has launched "A Closer Look at Stem Cell Treatments" (www.closerlookatstemcells.org), a Web site to arm patients, their families and doctors with information they need to make decisions about stem cell treatments.
Around 15% of ovarian cancer cases are linked to genetic mutations such as BRCA1, BRCA2 and Lynch Syndrome, which increase an individual's likelihood of developing ovarian and other cancers. This equates to over 1,000 women a year in the UK whose lives could potentially be saved.
The Center for Infection and Immunity at Columbia University's Mailman School today announced that the U.S. Food and Drug Administration has issued an Emergency Use Authorization for the CII-ArboViroPlex rRT-PCR Test, the first multiplex assay that simultaneously tests for the presence of Zika virus, all serotypes of dengue virus, chikungunya virus, and West Nile virus, as well as a host gene that ensures the accuracy of results.
Medtronic, Inc. (NYSE:MDT) today announced financial results for its first quarter of fiscal year 2010, which ended July 31, 2009.
› Verified 1 days ago
Heinrich H.m. Grube, MD Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 35 Medical Center Parkway, Suite 101, Augusta, ME 04330 Phone: 207-430-4321 Fax: 207-430-4320 | |
Richard Jay Raskin, M.D. Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 15 Enterprise Dr Ste 200, Augusta, ME 04330 Phone: 207-621-9580 Fax: 207-621-9581 | |
Navdeep Kaur, M.D. Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 35 Medical Center Pkwy, Augusta, ME 04330 Phone: 207-626-1000 Fax: 207-621-7277 | |
Dr. Timothy John Richardson, M.D. Cardiovascular Disease Medicare: Medicare Enrolled Practice Location: 1 Va Ctr, Mdp 11, Augusta, ME 04330 Phone: 207-623-5757 Fax: 207-623-5792 | |
Erin Marie Dauchy, D.O. Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 361 Old Belgrade Rd, Augusta, ME 04330 Phone: 207-621-6100 | |
Dr. Irvin L Paradis, MD Cardiovascular Disease Medicare: Not Enrolled in Medicare Practice Location: 1 Va Ctr, Togus Vamc, Augusta, ME 04330 Phone: 207-623-8411 Fax: 207-621-7391 | |
Dr. Ramon Elias Cheleuitte, MD Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 12 Spruce St, Suite 7, Augusta, ME 04330 Phone: 207-621-2500 Fax: 207-621-9766 |